Boule Diagnostics Logo

Boule Diagnostics

Provider of hematology systems for decentralized human and veterinary markets.

BOUL | ST

Overview

Corporate Details

ISIN(s):
SE0011231158
LEI:
213800IK1TGY858TKZ45
Country:
Sweden
Address:
DOMNARVSGATAN 4, 163 53 SPÅNGA

Description

Boule Diagnostics is a global provider of diagnostic solutions specializing in hematology. The company develops, manufactures, and markets systems and consumables for blood diagnostics, including hematology analyzers, clinical chemistry analyzers, and associated reagents, controls, and calibrators. Its products are tailored for decentralized healthcare settings in both the human and veterinary markets, such as smaller laboratories and clinics. The company aims to enhance global healthcare access by providing high-quality instruments that deliver timely and accurate blood test results.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-05 08:25
Boule Diagnostics meddelar att VD lämnar och organisationen förbereder sig för …
Swedish 83.7 KB
2025-12-05 08:25
Boule Diagnostics Announces CEO Transition as Organization Prepares for Next Ch…
English 83.6 KB
2025-11-21 16:00
Boule Diagnostics – Nomination Committee for the Annual General Meeting 2026
English 78.2 KB
2025-11-21 16:00
Boule Diagnostics – Valberedning inför årsstämman 2026
Swedish 77.9 KB
2025-10-29 11:19 Swedish 10.0 KB
2025-10-24 08:00 Swedish 477.6 KB
2025-10-24 08:00 English 480.3 KB
2025-10-13 08:35
Boule Diagnostics CFO lämnar för ny möjlighet
Swedish 54.9 KB
2025-10-13 08:35
Boule Diagnostics Announces CFO Departure for New Opportunity
English 55.8 KB
2025-07-21 10:20 Swedish 10.5 KB
2025-07-18 12:43 Swedish 10.5 KB
2025-07-18 08:00 Swedish 561.0 KB
2025-07-18 08:00 English 549.3 KB
2025-05-07 17:45
Kommuniké från Boule Diagnostics årsstämma den 7 maj 2025
Swedish 49.2 KB
2025-05-07 17:45
Bulletin from the Annual General Meeting May 7, 2025 in Boule Diagnostics
English 49.6 KB

Automate Your Workflow. Get a real-time feed of all Boule Diagnostics filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Boule Diagnostics

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Boule Diagnostics via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-10-30 Emil Hjalmarsson Other Buy 900,000 6,408,000.00 SEK
2024-10-30 Torben Jörgensen Other Buy 100,000 712,000.00 SEK
2024-10-30 Emil Hjalmarsson Other Buy 65,000 462,800.00 SEK
2023-05-15 Torben Jörgensen Other Buy 5,000 54,000.00 SEK
2023-05-03 Torben Jörgensen Other Buy 10,000 120,000.00 SEK
2023-04-03 Torben Jörgensen Other Buy 5,000 60,000.00 SEK
2023-02-27 Jan Benjaminson Other Buy 8,000 102,000.00 SEK
2023-02-03 Yvonne Mårtensson Other Buy 7,083 100,224.45 SEK
2022-12-16 Jesper Söderqvist Other Buy 2,678 34,680.10 SEK
2022-12-15 Jesper Söderqvist Other Buy 55,034 706,086.22 SEK

Peer Companies

Acurx Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing a new class of antibiotics for priority pathogens.
United States of America
ACXP
Adaptimmune Therapeutics PLC Logo
Commercial-stage biopharma developing TCR T-cell therapies for solid tumors.
United States of America
ADAP
ADBIOTECH Co.,Ltd. Logo
Develops IgY-based immune antibodies as alternatives to vaccines and antibiotics.
South Korea
179530
ADC Therapeutics SA Logo
Commercial-stage biotech developing antibody-drug conjugates for cancer therapy.
United States of America
ADCT
Addex Therapeutics Ltd. Logo
Clinical-stage biopharma developing allosteric modulators for neurological disorders.
Switzerland
ADXN
ADIAL PHARMACEUTICALS, INC. Logo
A clinical-stage biopharma developing genetically targeted therapies for addiction.
United States of America
ADIL
Adicet Bio, Inc. Logo
Develops allogeneic gamma delta T cell therapies for cancer and autoimmune diseases.
United States of America
ACET
Adlai Nortye Ltd. Logo
A clinical-stage biopharma firm developing cancer immunotherapies and RAS-targeting drugs.
United States of America
ANL
ADMA BIOLOGICS, INC. Logo
Biopharmaceutical company that develops and manufactures plasma-derived biologics.
United States of America
ADMA
Adverum Biotechnologies, Inc. Logo
A clinical-stage company developing gene therapies for ocular diseases.
United States of America
ADVM

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.